Related references
Note: Only part of the references are listed.NF-κB mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance
Suman Dasgupta et al.
BIOCHEMICAL JOURNAL (2010)
The impact of liver fat vs visceral fat in determining categories of prediabetes
K. Kantartzis et al.
DIABETOLOGIA (2010)
Serum fetuin A/α2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis
Yusuf Yilmaz et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2010)
AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives
B. Viollet et al.
ACTA PHYSIOLOGICA (2009)
High Glucose Induces Transactivation of the alpha 2-HS Glycoprotein Gene Through the ERK1/2 Signaling Pathway
Hiroshi Takata et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2009)
Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
John Willy Haukeland et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Plasma Fetuin-A Levels and the Risk of Myocardial Infarction and Ischemic Stroke
Cornelia Weikert et al.
CIRCULATION (2008)
Fetuin-A and Its Relation to Metabolic Syndrome and Fatty Liver Disease in Obese Children Before and After Weight Loss
Thomas Reinehr et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production
Anita M. Hennige et al.
PLOS ONE (2008)
Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease
G. Svegliati-Baroni et al.
GUT (2007)
Non-alcoholic fatty liver disease
Einar Bjornsson et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2007)
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2
John Willy Haukeland et al.
JOURNAL OF HEPATOLOGY (2006)
Association between human fetuin-A and the metabolic syndrome - Data from the Heart and Soul Study
JH Ix et al.
CIRCULATION (2006)
Liver fibrosis
R Bataller et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
α2HS-glycoprotein, an antagonist of transforming growth factor β in vivo, inhibits intestinal tumor progression
CJ Swallow et al.
CANCER RESEARCH (2004)
Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A
B Denecke et al.
BIOCHEMICAL JOURNAL (2003)
The serum protein α2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification
C Schäfer et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
G Marchesini et al.
HEPATOLOGY (2003)
Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene
ST Mathews et al.
DIABETES (2002)
α2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor
ST Mathews et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2000)
Share Paper
